Australia - English - Department of Health (Therapeutic Goods Administration)

healthcare innovations australia pty ltd - 35225 - pressure alleviation pad, - pressure allieviation pad used for the prevention and relief of pressure sores or decubitus ulcers occurring on parts of the patients body that are prone to this. it is used for patients where he/she are undergoing a long treatment where the body is immobilised or disable, infirm persons who are confined to a seated position for long periods

Australia - English - Department of Health (Therapeutic Goods Administration)

siemens healthcare pty ltd - ct873 - special coagulation ivds - for in vitro diagnostic use in the quantitative and/or qualitative determination of tests associated with the coagulation cascade.

Australia - English - Department of Health (Therapeutic Goods Administration)

medtronic australasia pty ltd - 38771 - surgical plant polysaccharide haemostatic agent - veriset? hemostatic patch is composed of a peg (polyethylene glycol) hydrogel and oxidised cellulose. when exposed to the physiological fluids, veriset is activated and a gel is formed. the combination of the oxidised cellulose and the resultant gel initiates the clotting cascade and acts as a tamponade, physically stemming the flow of a broad spectrum of active bleeding. veriset is intended for use in surgical procedures (except neurological, orthopedic, ophthalmic, and respiratory) as an adjunct to hemostasis when the control of capillary, venous, and arterial bleeding by conventional procedures is ineffective or impractical

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ceva animal health pty ltd - copper indomethacin - oral tablet - copper indomethacin mineral-copper active 2.0 mg/tb - musculoskeletal system - dog | bitch | castrate | puppy - anti-inflammatory agent | antipyretic | bone soreness | bruising | bursitis | inflammatory rheumatic arthrit | joint disease | ligament sprains | muscle soreness | osteoarthritis | platelet activity | rheumatism | sprains | strains | tendon sprains | traumatic swelling

Israel - English - Ministry of Health

novartis israel ltd - omalizumab - powder and solvent for solution for injection - omalizumab 150 mg/dose - omalizumab - omalizumab - allergic asthma xolair is indicated for patients 6 to 12 years of age with severe persistent asthma and for patients 12 years of age and older with moderate to severe persistent asthma, who have a positive skin test or in vitro reactivity to a perennial aeroallergen and whose symptoms are inadequately controlled with inhaled corticosteroids. xolair has been shown to decrease the incidence of asthma exacerbations in these patients. limitations of use: xolair is not indicated for the relief of acute bronchospasm or status asthmaticus. xolair is not indicated for the treatment of other allergic conditions.chronic rhinosinusitis with nasal polyps (crswnp) xolair is indicated as an add-on therapy with intranasal corticosteroids (inc) for the treatment of adults (18 years and above) with severe crswnp for whom therapy with inc does not provide adequate disease control.chronic spontaneous urticaria (csu) xolair is indicated as add-on therapy for the treatment of chronic spontaneous urticaria in adult and adolescent (12 years and above) patients with inadequate response to h1 antihistamine treatment.

Singapore - English - HSA (Health Sciences Authority)

boehringer ingelheim singapore pte. ltd. - dabigatran etexilate mesilate 126.83 mg eqv dabigatran etexilate - capsule - 110 mg - dabigatran etexilate mesilate 126.83 mg eqv dabigatran etexilate 110 mg

Singapore - English - HSA (Health Sciences Authority)

boehringer ingelheim singapore pte. ltd. - dabigatran etexilate mesilate 86.48mg eqv dabigatran etexilate - capsule - 75 mg - dabigatran etexilate mesilate 86.48mg eqv dabigatran etexilate 75 mg

Singapore - English - HSA (Health Sciences Authority)

specialised therapeutics asia pte ltd - trabectedin - injection, powder, for solution - 1.0mg/vial - trabectedin 1.0mg/vial

Singapore - English - HSA (Health Sciences Authority)

dch auriga singapore - fondaparinux sodium - injection, solution - 5.0 mg - fondaparinux sodium 5.0 mg/0.4 ml

Singapore - English - HSA (Health Sciences Authority)

dch auriga singapore - fondaparinux sodium - injection, solution - 7.5 mg - fondaparinux sodium 7.5 mg/0.6 ml